- Home
- WAVE vs INKT Comparison
WAVE vs INKT Comparison
Compare WAVE & INKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WAVE
- INKT
- Stock Information
- Founded
- WAVE 2011
- INKT 2017
- Country
- WAVE Israel
- INKT United States
- Employees
- WAVE N/A
- INKT N/A
- Industry
- WAVE Electric Utilities: Central
- INKT Medicinal Chemicals and Botanical Products
- Sector
- WAVE Utilities
- INKT Health Care
- Exchange
- WAVE Nasdaq
- INKT Nasdaq
- Market Cap
- WAVE 53.4M
- INKT 75.7M
- IPO Year
- WAVE 2021
- INKT 2021
- Fundamental
- Price
- WAVE $8.58
- INKT $16.83
- Analyst Decision
- WAVE Strong Buy
- INKT Hold
- Analyst Count
- WAVE 1
- INKT 3
- Target Price
- WAVE $15.00
- INKT $37.50
- AVG Volume (30 Days)
- WAVE 25.0K
- INKT 2.9M
- Earning Date
- WAVE 08-28-2025
- INKT 08-12-2025
- Dividend Yield
- WAVE N/A
- INKT N/A
- EPS Growth
- WAVE N/A
- INKT N/A
- EPS
- WAVE N/A
- INKT N/A
- Revenue
- WAVE $168,000.00
- INKT N/A
- Revenue This Year
- WAVE $325.00
- INKT N/A
- Revenue Next Year
- WAVE $85.71
- INKT N/A
- P/E Ratio
- WAVE N/A
- INKT N/A
- Revenue Growth
- WAVE N/A
- INKT N/A
- 52 Week Low
- WAVE $2.50
- INKT $4.56
- 52 Week High
- WAVE $17.63
- INKT $76.00
- Technical
- Relative Strength Index (RSI)
- WAVE 59.41
- INKT 49.44
- Support Level
- WAVE $7.53
- INKT $18.54
- Resistance Level
- WAVE $9.83
- INKT $20.25
- Average True Range (ATR)
- WAVE 0.76
- INKT 8.24
- MACD
- WAVE 0.11
- INKT -1.13
- Stochastic Oscillator
- WAVE 57.48
- INKT 13.41
About WAVE Eco Wave Power Global AB (publ)
Eco Wave Power Global AB is a Sweden-based wave energy company engaged in the development of a smart and cost-efficient WEC, technology that converts ocean and sea waves into clean electricity. Its WEC technology employs units of point absorber floating devices, referred to as floaters, which are installed on existing marine structures such as piers, breakwaters, and jetties, or in locations in which such marine structures are required. Geographical presence in Israel, USA and Mexico.
About INKT MiNK Therapeutics Inc.
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. The company is advancing a pipeline of both native and next generation engineered iNKT programs, with a platform designed to facilitate scalable and reproducible manufacturing for off-the-shelf delivery.